EX-23.1 17 d445089dex231.htm EX-23.1 EX-23.1

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

 

We consent to the reference to our firm under the caption “Experts” and to the use of our report dated October 4, 2017, in the Registration Statement and related Prospectus of Apellis Pharmaceuticals, Inc. dated October 13, 2017.

 

/s/ Ernst & Young LLP

Louisville, KY

October 13, 2017